ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "BD sells surgical instrumentation assets, CorWave raises $64M to manufacture LVADs"
Episode Synopsis
The partnership between Nuwellis and DaVita to launch an ultrafiltration therapy pilot program is an exciting development in the field of renal care. The agreement enables Nuwellis — formerly CHF Solutions — to pilot its Aquadex ultrafiltration therapy within selected U.S. markets. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the partnership in detail and what executives say about it.
CorWave's successful fundraising of $64 million is a significant milestone for the company as it prepares to manufacture its left ventricular assist device (LVAD). LVADs play a critical role in supporting patients with advanced heart failure, and CorWave's technology has the potential to improve patient outcomes and enhance their quality of life. Learn more about the company's technology and other developments in today's episode.
Avanos Medical's decision to acquire Diros Technology is a strategic move demonstrating the company's commitment to expanding its portfolio and addressing unmet needs in the medical device market. Diros Technology makes radiofrequency products that are used to treat chronic pain conditions. Whooley explains how the acquisition will support Avanos' offerings and when the transaction will be completed.
The FDA approval of Surmodics' SurVeil drug-coated balloon highlights the continued advancements in interventional cardiology and the increasing availability of innovative treatment options for patients with peripheral arterial disease (PAD). Hear how the technology stacks up against other devices in the market and how the company overcame being "unapprovable" earlier this year.
BD's decision to sell its surgical instrumentation assets to Steris for $540 million marks a strategic move to streamline its portfolio and focus on core areas of expertise. This transaction enables BD to allocate resources more effectively and invest in research and development efforts that align with its long-term growth strategy. Whooley and Kirsh explain how BD will expand and how the acquisition will affect Steris' bottom line.
Check out the show notes and links to the stories we discussed today at MassDevice.com/podcast.
CorWave's successful fundraising of $64 million is a significant milestone for the company as it prepares to manufacture its left ventricular assist device (LVAD). LVADs play a critical role in supporting patients with advanced heart failure, and CorWave's technology has the potential to improve patient outcomes and enhance their quality of life. Learn more about the company's technology and other developments in today's episode.
Avanos Medical's decision to acquire Diros Technology is a strategic move demonstrating the company's commitment to expanding its portfolio and addressing unmet needs in the medical device market. Diros Technology makes radiofrequency products that are used to treat chronic pain conditions. Whooley explains how the acquisition will support Avanos' offerings and when the transaction will be completed.
The FDA approval of Surmodics' SurVeil drug-coated balloon highlights the continued advancements in interventional cardiology and the increasing availability of innovative treatment options for patients with peripheral arterial disease (PAD). Hear how the technology stacks up against other devices in the market and how the company overcame being "unapprovable" earlier this year.
BD's decision to sell its surgical instrumentation assets to Steris for $540 million marks a strategic move to streamline its portfolio and focus on core areas of expertise. This transaction enables BD to allocate resources more effectively and invest in research and development efforts that align with its long-term growth strategy. Whooley and Kirsh explain how BD will expand and how the acquisition will affect Steris' bottom line.
Check out the show notes and links to the stories we discussed today at MassDevice.com/podcast.
More episodes of the podcast Fast Five Medtech News Podcast
Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent
15/03/2024
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
14/03/2024
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
12/03/2024
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
08/03/2024
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
06/03/2024
In God we trust